Tonix is enrolling in a Phase 3 study for Fibromyalgia, and Phase 2 studies for Chronic Migraine and Major Depressive Disorder. Please visit Clinical Trials.
Email Alerts
Please fill out the form below to receive company press releases via email when they occur.